The receptor molecule AXL, a member of the TAM (Tyro3, AXL, Mer) family of receptor tyrosine kinases, plays a role in cancer progression, metastasis and treatment resistance, and high AXL expression is often linked to a poorer prognosis in brain cancer patients [9]. The gene discussed is AXL; the disease is brain cancer.